The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.
1 Primary · 0 Secondary · Reporting Duration: 3-10 days
60 Total Participants · 2 Treatment Groups
Primary Treatment: TENS device · No Placebo Group · N/A
Age 18 - 70 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|Did not meet criteria||100.0%|